talazoparib,rucaparib,abiraterone,enzalutamide
pfizer,astellas,clovis oncology
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'triton3', 'gu ', 'talapro-2']
excited to be in san francisco for gu asco 2023! fantastic start, with triton3 and talapro-2 showing promise for incorporating parp inhibition in earlier lines of therapy for prostate cancer but no os benefit shown yet, pending further maturation. #gu23 
Hematologist/Oncologist @MCIStrong @mhshospital | Tweets are my own.